Refractory Anemia With Excess Blasts in Transformation Completed Phase 3 Trials for Aldesleukin (DB00041)

Also known as: Refractory anemia with excess blasts in transformation / Acute myeloblastic leukemia, minimal differentiation / Refractory anaemia with excess blasts in transformation / Myelodysplastic syndrome transformation